Is This Right for Me? Peptides: BPC-157, Growth Hormones and the Gray Market

Commune with Jeff Krasno

Commune Media

Society & Culture, Health & Fitness

4.5 • 673 Ratings

🗓️ 15 April 2026

⏱️ 42 minutes

🔗️ Recording | iTunes | RSS

🧾️ Download transcript

Summary

In March 2026, the largest gray-market peptide vendor in the U.S. went dark overnight. No refunds, and a wave of uncertainty about what these products actually are, how they’re sourced, and whether they’re worth the risk.In this episode, Jeff works through what peptides actually are, where the science holds up and where it doesn't, and what the gray-market collapse means for anyone paying attention to this space. Topics covered: BPC-157, CJC-1295, ipamorelin, and TB-500: what the research actually shows Why are oral peptide capsules mostly expensive amino acids The sourcing landscape: FDA-approved, compounding pharmacies, and gray market Who peptide therapy may be right for, and who should wait Free, evidence-backed alternatives for GH optimization and injury recovery This episode is for anyone who's been curious about peptide injections and wants the honest answer, not the Joe Rogan version. This episode was made possible by: Sunlighten: Visit sunlighten.com/commune Up to 2,100 off saunas and $50 off Red Light Products with code “COMMUNE” Bon Charge: Get 15% off when you order at boncharge.com and use promo code COMMUNE Stemregen: Get 20% off your first order at stemregen.co/commune with the code COMMUNEPOD Vivobarefoot: Try Vivobarefoot risk-free with a 100-day return guarantee, and get 15% off your order at vivobarefoot.com/commune. Beyond Biohacking: Save $400 on any ticket with code COMMUNE400 at beyondconference.com.

Transcript

Click on a timestamp to play from that location

0:00.0	Welcome to the commune podcast. My name is Jeff Krasnow. Okay, this is the second episode in a series
0:06.3	that I'm calling, Is This Right for Me? Where I take a hard honest look at the protocols,
0:11.8	treatments, and trends flooding our feeds and try to answer a deceptively simple question. Should I
0:18.7	actually be doing this? Well, last week, I dove into GLP-1s, which,
0:24.3	technically speaking, are peptides. But culturally, they've been spun off into their own category.
0:30.6	They are in the zeitgeist. As epic has basically become cocktail party conversation at this
0:36.5	juncture.
0:43.8	GLP ones are also patentable and are a massive source of revenue for big pharma.
0:50.2	Peptides like BPC 157 and TB 500, these are not patentable.
0:56.0	And they still live a little further out on the cultural frontier. And here I am on that frontier.
0:59.0	Despite being a tropanaphob and avoiding needles wherever possible,
1:05.0	I have become increasingly interested in carefully experimenting with modalities
1:10.0	that might improve some real physical issues
1:12.9	that I've been dealing with. So yes, I am now reconstituting and injecting peptides,
1:19.6	which is a very clinical way of saying, I take a small vial of powder, mix it with bacteriostatic
1:26.0	water, draw it into a syringe, and inject it into my body on a daily basis.
1:32.0	Right now, I'm experimenting with what's colloquially known as the Wolverine stack, BPC 157, and TB 500.
1:40.3	I'm injecting subcutaneously, usually into a little bit of muffin top or sometimes into my
1:46.5	glute. Why? Well, because I have some chronic knee pain that includes some inflammation
1:52.0	and tendon and ligament irritation. I have pain right below the patella on the right knee,
1:59.3	especially when I go upstairs.
2:01.8	And peptides can increase blood flow and reduce inflammation and swelling.
	...

Please login to see the full transcript.

Previous episode | Next episode

Disclaimer: The podcast and artwork embedded on this page are from Commune Media, and are the property of its owner and not affiliated with or endorsed by Tapesearch.

Generated transcripts are the property of Commune Media and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.